JP2023509441A5 - - Google Patents

Info

Publication number
JP2023509441A5
JP2023509441A5 JP2022540904A JP2022540904A JP2023509441A5 JP 2023509441 A5 JP2023509441 A5 JP 2023509441A5 JP 2022540904 A JP2022540904 A JP 2022540904A JP 2022540904 A JP2022540904 A JP 2022540904A JP 2023509441 A5 JP2023509441 A5 JP 2023509441A5
Authority
JP
Japan
Prior art keywords
drawings
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022540904A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023509441A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/067612 external-priority patent/WO2021138525A1/en
Publication of JP2023509441A publication Critical patent/JP2023509441A/ja
Publication of JP2023509441A5 publication Critical patent/JP2023509441A5/ja
Pending legal-status Critical Current

Links

JP2022540904A 2019-12-31 2020-12-31 トファシチニブおよびフィンゴリモドを含む局所組成物 Pending JP2023509441A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962955847P 2019-12-31 2019-12-31
US62/955,847 2019-12-31
US202063066717P 2020-08-17 2020-08-17
US63/066,717 2020-08-17
US202063086442P 2020-10-01 2020-10-01
US202063086275P 2020-10-01 2020-10-01
US63/086,275 2020-10-01
US63/086,442 2020-10-01
PCT/US2020/067612 WO2021138525A1 (en) 2019-12-31 2020-12-31 Topical composition comprising tofacitinib and fingolimod

Publications (2)

Publication Number Publication Date
JP2023509441A JP2023509441A (ja) 2023-03-08
JP2023509441A5 true JP2023509441A5 (cg-RX-API-DMAC7.html) 2024-01-17

Family

ID=74285586

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022540904A Pending JP2023509441A (ja) 2019-12-31 2020-12-31 トファシチニブおよびフィンゴリモドを含む局所組成物

Country Status (9)

Country Link
US (1) US20230037905A1 (cg-RX-API-DMAC7.html)
EP (1) EP4084776A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023509441A (cg-RX-API-DMAC7.html)
AU (1) AU2020417290A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022012917A2 (cg-RX-API-DMAC7.html)
CA (1) CA3163530A1 (cg-RX-API-DMAC7.html)
IL (1) IL294239A (cg-RX-API-DMAC7.html)
TW (1) TW202135825A (cg-RX-API-DMAC7.html)
WO (1) WO2021138525A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US12661407B2 (en) 2010-04-08 2026-06-23 Journey Medical Corporation Compositions, gels and foams with rheology modulators and uses thereof
JP7324210B2 (ja) * 2018-01-31 2023-08-09 ティダブリューアイ・バイオテクノロジー・インコーポレイテッド トファシチニブを含む局所製剤
CN116437921A (zh) * 2020-09-28 2023-07-14 株式会社Lg化学 鞘氨醇-1-磷酸酯受体激动剂的用途
CN120168480A (zh) * 2025-04-17 2025-06-20 四川省医学科学院·四川省人民医院 托法替尼在制备治疗干性年龄相关性黄斑变性的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874794A (en) 1989-04-28 1989-10-17 Lidak Biopharmaceuticals Inflammatory disease treatment
US9474720B2 (en) 2013-11-04 2016-10-25 BioPharmX, Inc. Dosage form comprising an active ingredient and a plurality of solid porous microcarriers

Similar Documents

Publication Publication Date Title
JP2020127044A5 (cg-RX-API-DMAC7.html)
JP2022191211A5 (cg-RX-API-DMAC7.html)
JP2024023385A5 (cg-RX-API-DMAC7.html)
JP2021169491A5 (cg-RX-API-DMAC7.html)
JP2022028828A5 (cg-RX-API-DMAC7.html)
JP2020127428A5 (cg-RX-API-DMAC7.html)
JP2022025124A5 (cg-RX-API-DMAC7.html)
JP2021185136A5 (cg-RX-API-DMAC7.html)
JP2022068302A5 (cg-RX-API-DMAC7.html)
JP2022523200A5 (cg-RX-API-DMAC7.html)
JP2023518821A5 (cg-RX-API-DMAC7.html)
JP2021512414A5 (cg-RX-API-DMAC7.html)
JP2021038271A5 (cg-RX-API-DMAC7.html)
JP2023022224A5 (cg-RX-API-DMAC7.html)
JP2022538797A5 (cg-RX-API-DMAC7.html)
JP2022543046A5 (cg-RX-API-DMAC7.html)
JP2025506484A5 (cg-RX-API-DMAC7.html)
JP2019536002A5 (cg-RX-API-DMAC7.html)
JP2020171301A5 (cg-RX-API-DMAC7.html)
JP2023085551A5 (cg-RX-API-DMAC7.html)
JP2022060295A5 (cg-RX-API-DMAC7.html)
JP2020120660A5 (cg-RX-API-DMAC7.html)
JP2022505647A5 (cg-RX-API-DMAC7.html)
JP2022537813A5 (cg-RX-API-DMAC7.html)
JP2024059648A5 (cg-RX-API-DMAC7.html)